SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti-Trypanosoma brucei Agent
摘要:
Chemical modulation of the flavonol 2-(benzo[d] [1,3]dioxo1-5-y1)-chromen-4-one (1), a promising anti-Trypanosomatid agent previously identified, was evaluated through a phenotypic screening approach. Herein, we have performed structure activity relationship studies around hit compound 1. The pivaloyl derivative (13) showed significant anti-T. brucei activity (EC50 = 1.1 1iM) together with a selectivity index higher than 92. The early in vitro ADME-tox properties (cytotoxicity, mitochondria] toxicity, cytochrome P450 and hERG inhibition) were determined for compound 1 and its derivatives, and these led to the identification of some liabilities. The 1,3-benzodioxole moiety in the presented compounds confers better in vivo pharmacokinetic properties than those of classical flavonols. Further studies using different delivery systems could lead to an increase of compound blood levels.
Ozawa et al., Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1951, vol. 71, p. 1178,1182
作者:Ozawa et al.
DOI:——
日期:——
Marathe, Journal of the University of Poona, Science and Technology, 1958, # 14, p. 63,66
作者:Marathe
DOI:——
日期:——
CHINCHOLKAR M. M.; KAKADE B. S.; JAMODE V. S., INDIAN J. CHEM., 1980, B 17, NO 6, 629-630
作者:CHINCHOLKAR M. M.、 KAKADE B. S.、 JAMODE V. S.
DOI:——
日期:——
JOSHI, U. K.;KELKAR, R. M.;PARADKAR, M. V., INDIAN J. CHEM., 1983, 22, N 11, 1151-1152
作者:JOSHI, U. K.、KELKAR, R. M.、PARADKAR, M. V.
DOI:——
日期:——
ESTROGEN RECEPTOR ALPHA COLIGANDS, AND METHODS OF USE THEREOF
申请人:The Regents of the University of California
公开号:US20190008797A1
公开(公告)日:2019-01-10
Provided herein is a coligand for the estrogen receptor (ER) a subunit, and methods of use thereof in treating conditions associated with ER signaling in an individual. The present ERα coligand may be a cell type-selective, allosteric modulator of ERα signaling. The ERα coligand, when administered to an individual, may modulate ER agonist-dependent signaling in a tissue-selective manner.